PharmaNordic ApS Financials, key figures and credit report
Gross profit - 197.7 kDKK FY 2025 -133.5% vs 2024
EBIT - 362.1 kDKK FY 2025 -358.8% vs 2024
Net debt -11.3 kDKK FY 2025 +98.7% vs 2024
Quick ratio 28.1 FY 2025 +25.5 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 738.34 | 574.64 | 722.70 | 590.57 | - 197.66 |
| Employee benefit expenses | - 375.32 | - 403.11 | - 428.83 | - 450.66 | - 164.44 |
| EBIT | 363.02 | 171.53 | 293.86 | 139.91 | - 362.11 |
| Other financial income | - 132.23 | 50.40 | 284.65 | 540.49 | 2 471.18 |
| Other financial expenses | -6.85 | 1.28 | -1.50 | -0.18 | |
| Net income from associates (fin.) | 125.00 | ||||
| Pre-tax profit | 223.95 | 223.20 | 577.02 | 680.23 | 2 234.07 |
| Income taxes | -79.55 | -39.92 | -61.66 | -32.45 | 79.62 |
| Net earnings | 144.39 | 183.29 | 515.36 | 647.77 | 2 313.70 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 291.98 | 342.38 | 626.95 | 1 159.75 | 3 630.74 |
| Investments total | 291.98 | 342.38 | 626.95 | 1 159.75 | 3 630.74 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 100.00 | 249.25 | |||
| Current amounts owed by group member comp. | 288.20 | 220.24 | 317.94 | ||
| Current deferred tax assets | 79.62 | ||||
| Short term receivables total | 100.00 | 537.46 | 220.24 | 397.56 | |
| Cash and bank deposits | 660.50 | 506.83 | 378.64 | 881.55 | 11.29 |
| Cash and cash equivalents | 660.50 | 506.83 | 378.64 | 881.55 | 11.29 |
| Balance sheet total (assets) | 952.48 | 949.21 | 1 543.05 | 2 261.54 | 4 039.59 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Other reserves | 318.63 | 603.20 | 1 136.00 | 3 606.99 | |
| Retained earnings | 295.50 | 121.27 | 19.99 | 2.54 | -1 945.67 |
| Profit of the financial year | 144.39 | 183.29 | 515.36 | 647.77 | 2 313.70 |
| Shareholders equity total | 489.90 | 673.18 | 1 188.55 | 1 836.32 | 4 025.01 |
| Non-current liabilities total | |||||
| Current trade creditors | 6.00 | 6.00 | 6.00 | 306.00 | 6.00 |
| Current owed to group member | 128.01 | 161.63 | |||
| Short-term deferred tax liabilities | 79.55 | 39.92 | 64.66 | 32.45 | |
| Other non-interest bearing current liabilities | 377.03 | 102.10 | 122.21 | 86.77 | 8.57 |
| Current liabilities total | 462.58 | 276.03 | 354.50 | 425.22 | 14.57 |
| Balance sheet total (liabilities) | 952.48 | 949.21 | 1 543.05 | 2 261.54 | 4 039.59 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated